Nemaura Medical Inc
(NMRD)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 03/31
(Values in U.S. thousands)
| 12-2023 | 09-2023 | 06-2023 | 03-2023 | 12-2022 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -5,968 | -3,807 | -2,603 | -14,144 | -9,461 |
| Depreciation Amortization | 2,113 | 668 | 263 | 1,424 | 4,421 |
| Accounts receivable | -120 | -825 | -583 | 1,022 | 76 |
| Accounts payable and accrued liabilities | 26 | 92 | -70 | 190 | 35 |
| Other Working Capital | -851 | -1,027 | -561 | -2,054 | -1,686 |
| Other Operating Activity | -2,402 | -826 | 1,033 | 5,110 | 525 |
| Operating Cash Flow | $-7,204 | $-5,724 | $-2,521 | $-8,452 | $-6,090 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -77 | -66 | -29 | -539 | -439 |
| Investing Cash Flow | $-77 | $-66 | $-29 | $-539 | $-439 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | 6,500 | 6,500 | N/A | N/A | 4,700 |
| Debt Repayment | N/A | N/A | N/A | 4,700 | N/A |
| Common Stock Issued | N/A | N/A | N/A | 8,394 | 1 |
| Other Financing Activity | -9,178 | -6,178 | -3,600 | -11,012 | -7,975 |
| Financing Cash Flow | $-2,678 | $322 | $-3,600 | $2,082 | $-3,274 |
| Exchange Rate Effect | -9 | -258 | 55 | -735 | -606 |
| Beginning Cash Position | 10,105 | 10,105 | 10,105 | 17,749 | 17,749 |
| End Cash Position | 137 | 4,378 | 4,010 | 10,105 | 7,341 |
| Net Cash Flow | $-9,968 | $-5,727 | $-6,095 | $-7,644 | $-10,408 |
| Free Cash Flow | |||||
| Operating Cash Flow | -7,204 | -5,724 | -2,521 | -8,452 | -6,090 |
| Capital Expenditure | -77 | -66 | -29 | -539 | -439 |
| Free Cash Flow | -7,281 | -5,791 | -2,551 | -8,991 | -6,529 |